Schedule 13G
AGL Schedule 13G filing by Goldman Sachs Group
Goldman Sachs Group reported beneficial ownership of 1.0K shares, representing 6.1% of agilon health, inc. in this filing.
FiledMay 13, 2026
Ownership dateMar 31, 2026
Reported shares1.0K
Reported ownership6.1%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
0
Shared voting power
1.0K
Sole dispositive power
0
Shared dispositive power
1.0K
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$72.01as of May 13, 2026
Latest tracked price$86.83as of Aug 6, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- Goldman Sachs Group
- CIK
- CIK0000886982
- Accession
- 0000886982-26-000243
- Form
- Schedule 13G
Read the filing in context